Edition:
United Kingdom

Accelerate Diagnostics Inc (AXDX.OQ)

AXDX.OQ on NASDAQ Stock Exchange Capital Market

25.75USD
23 Feb 2018
Change (% chg)

$-0.20 (-0.77%)
Prev Close
$25.95
Open
$26.00
Day's High
$26.10
Day's Low
$25.25
Volume
45,539
Avg. Vol
119,824
52-wk High
$30.45
52-wk Low
$16.85

Chart for

About

Accelerate Diagnostics, Inc. is an in vitro diagnostics company engaged in providing solutions that develop patient outcomes through the diagnosis of serious infections. The Company's in vitro diagnostic platform, the Accelerate Pheno system utilizes genotypic technology to identify (ID), infectious pathogens and phenotypic... (more)

Overall

Beta: 2.04
Market Cap(Mil.): $1,227.62
Shares Outstanding(Mil.): 55.30
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 148.59 16.60
EPS (TTM): -- -- --
ROI: -- 9.38 10.66
ROE: -- 14.72 14.30

BRIEF-Accelerate Diagnostics Qtrly Net Loss $0.27 Per Share

* ACCELERATE DIAGNOSTICS REPORTS Q4 AND FULL-YEAR FINANCIAL RESULTS FOR 2017

15 Feb 2018

BRIEF-Accelerate Diagnostics says ‍on Nov 14, board increased its size to 8 members​

* Accelerate Diagnostics says ‍on Nov 14, board increased size of board to 8 members​ - SEC Filing Source text: [http://bit.ly/2iocMIO] Further company coverage:

16 Nov 2017

BRIEF-Accelerate Diagnostics reports Q3 loss per share $0.31

* Accelerate Diagnostics Inc reports q3 2017 financial results

02 Nov 2017

BRIEF-Plaintiffs dismiss class action appeal against Accelerate Diagnostics

* Plaintiffs dismiss class action appeal against Accelerate Diagnostics

13 Sep 2017

Earnings vs. Estimates